1. Home
  2. SNSE vs RETO Comparison

SNSE vs RETO Comparison

Compare SNSE & RETO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNSE
  • RETO
  • Stock Information
  • Founded
  • SNSE 2005
  • RETO 1999
  • Country
  • SNSE United States
  • RETO China
  • Employees
  • SNSE N/A
  • RETO N/A
  • Industry
  • SNSE Biotechnology: Pharmaceutical Preparations
  • RETO Multi-Sector Companies
  • Sector
  • SNSE Health Care
  • RETO Consumer Discretionary
  • Exchange
  • SNSE Nasdaq
  • RETO Nasdaq
  • Market Cap
  • SNSE 9.3M
  • RETO 10.8M
  • IPO Year
  • SNSE 2021
  • RETO 2017
  • Fundamental
  • Price
  • SNSE $0.38
  • RETO $3.60
  • Analyst Decision
  • SNSE Strong Buy
  • RETO
  • Analyst Count
  • SNSE 4
  • RETO 0
  • Target Price
  • SNSE $4.25
  • RETO N/A
  • AVG Volume (30 Days)
  • SNSE 8.3M
  • RETO 20.7K
  • Earning Date
  • SNSE 05-08-2025
  • RETO 10-28-2024
  • Dividend Yield
  • SNSE N/A
  • RETO N/A
  • EPS Growth
  • SNSE N/A
  • RETO N/A
  • EPS
  • SNSE N/A
  • RETO N/A
  • Revenue
  • SNSE N/A
  • RETO $3,841,142.00
  • Revenue This Year
  • SNSE N/A
  • RETO N/A
  • Revenue Next Year
  • SNSE N/A
  • RETO N/A
  • P/E Ratio
  • SNSE N/A
  • RETO N/A
  • Revenue Growth
  • SNSE N/A
  • RETO N/A
  • 52 Week Low
  • SNSE $0.25
  • RETO $0.33
  • 52 Week High
  • SNSE $1.94
  • RETO $7.10
  • Technical
  • Relative Strength Index (RSI)
  • SNSE 48.32
  • RETO 53.65
  • Support Level
  • SNSE $0.33
  • RETO $3.05
  • Resistance Level
  • SNSE $0.39
  • RETO $3.81
  • Average True Range (ATR)
  • SNSE 0.05
  • RETO 0.37
  • MACD
  • SNSE 0.00
  • RETO -0.07
  • Stochastic Oscillator
  • SNSE 52.68
  • RETO 71.35

About SNSE Sensei Biotherapeutics Inc.

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).

About RETO ReTo Eco-Solutions Inc.

ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly-ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation and construction of urban ecological environments for capturing, controlling and re-using rainwater. It operates through four segments namely Machinery and Equipment sales, Construction materials sales, Municipal Construction Projects, and Technology Consulting and other services. The company earns its revenue from Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: